Home/Filings/4/0001178913-25-004151
4//SEC Filing

Abramov Dror Yosef 4

Accession 0001178913-25-004151

CIK 0002022416other

Filed

Dec 30, 7:00 PM ET

Accepted

Dec 31, 1:13 PM ET

Size

16.4 KB

Accession

0001178913-25-004151

Insider Transaction Report

Form 4
Period: 2025-02-09
Transactions
  • Award

    Ordinary Shares

    2025-02-09+794794 total
  • Award

    Stock Option (right to buy ordinary shares)

    2025-02-09+935935 total
    Exercise: $18.90From: 2026-02-09Exp: 2035-02-09Ordinary Shares (935 underlying)
Holdings
  • Ordinary Shares

    295
Footnotes (5)
  • [F1]Represents ordinary shares underlying RSUs granted to the Reporting Person by the Issuer. The shares subject to this award vest in full on the first anniversary of the date of grant, subject to the Reporting Person's continued service through such date.
  • [F2]The number of ordinary shares reported in this row has been adjusted retroactively to reflect a 1-for-15 reverse share split effected by the Issuer on July 29, 2025.
  • [F3]There were no transactions effected in respect of the ordinary shares reported in this row, and the holdings in this row are being included for informational purposes only.
  • [F4]The number of ordinary shares reported in this row has been adjusted downwards to reflect a 1-for-9 reverse share split effected by the Issuer on November 29, 2024 and a 1-for-15 reverse share split effected by the Issuer on July 29, 2025.
  • [F5]The number of options to purchase ordinary shares, and underlying ordinary shares, reported in this row have been adjusted downwards, and the exercise price of those options has been adjusted proportionately upwards, to reflect the 1-for-15 reverse share split effected by the Issuer on July 29, 2025.

Issuer

Silexion Therapeutics Corp

CIK 0002022416

Entity typeother

Related Parties

1
  • filerCIK 0002034083

Filing Metadata

Form type
4
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 1:13 PM ET
Size
16.4 KB